首页> 外文OA文献 >Biocompatibility of fluids for multiphase drops-in-drops microfluidics
【2h】

Biocompatibility of fluids for multiphase drops-in-drops microfluidics

机译:多相微滴流体的生物相容性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This paper addresses the biocompatibility of fluids and surfactants in the context of microfluidics and more specifically in a drops-in-drops system for mammalian cell based drug screening. In the drops-in-drops approach, three immiscible fluids are used to manipulate the flow of aqueous microliter-sized drops; it enables merging of drops containing cells with drops containing drugs within a Teflon tube. Preliminary tests showed that a commonly-used fluid and surfactant combination resulted in significant variability in gene expression levels in Jurkat cells after exposure to a drug for four hours. This result led to further investigations of potential fluid and surfactant combinations that can be used in microfluidic systems for medium to long-term drug screening. Results herein identify a fluid combination, HFE-7500 and 5-cSt silicone oil + 0.25% Abil EM180, which enabled the drops-in-drops approach; this combination also allowed gene expression at normal levels comparable with the conventional drug screening in both magnitude and variability.
机译:本文探讨了微流控技术中流体和表面活性剂的生物相容性,尤其是在基于哺乳动物细胞的药物筛选的点滴系统中。在逐滴法中,使用三种不混溶的流体来控制微升大小的水液滴的流动。它可以将含有细胞的液滴与含有聚四氟乙烯管中药物的液滴合并。初步测试表明,常用的液体和表面活性剂的组合在暴露于药物四个小时后导致Jurkat细胞中基因表达水平的显着变化。该结果导致了对潜在流体和表面活性剂组合的进一步研究,这些流体和表面活性剂组合可用于中长期药物筛选的微流体系统。本文的结果确定了流体组合HFE-7500和5-cSt硅油+ 0.25%Abil EM180,可实现逐滴法;这种组合还使得基因表达在幅度和变异性上都可以与常规药物筛选相比处于正常水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号